MHRA AI Airlock Phase 2: Seven AIaMD Evidence Case Studies
A 2026 analysis of MHRA AI Airlock Phase 2's seven cases, mapping intended purpose, AI-IVD validation, PCCPs and post-market evidence to practical UK development and NHS deployment decisions.